Besides Parkinson’s disease, what other condition involves L-DOPA use related to dopamine pathways?

Restless Legs Syndrome (RLS).

Although L-DOPA's paramount role is in Parkinson's disease management, its influence on dopamine pathways extends to other neurological or movement disorders. One notable secondary application mentioned is in the treatment of Restless Legs Syndrome, commonly abbreviated as RLS. RLS is characterized by a distinct, often uncomfortable, and irresistible urge to move the legs, an impulse that frequently intensifies during periods of rest or when a person is attempting to sleep, often worsening at night. While the underlying mechanism shares a connection with dopamine pathways, the specific treatment strategy, including dosage and formulation, used for RLS may differ considerably from the protocols established for managing the motor symptoms of Parkinson’s disease.